SENSEONICS HOLDINGS INC (SENS)

Company Profile

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 132 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Company Info

SENSEONICS HOLDINGS INC

20451 Seneca Meadows Pkwy

Germantown MARYLAND 20876

P: 13015157260

CEO: Timothy T. Goodnow

Employees: 132

Website: https://www.senseonics.com/